Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-κB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis

Coronary Artery Calcification Is an Independent Stroke Predictor in the General Population

(2013) Dirk M. Hermann et al.   STROKE

Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trials

(2013) Huseyin Naci et al.   European Journal of Preventive Cardiology

Effect of statin therapy on the progression of coronary atherosclerosis

(2012) Jinwei Tian et al.   BMC Cardiovascular Disorders

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

(2012) Allan Lipton et al.   EUROPEAN JOURNAL OF CANCER

Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability

(2011) Fabrizio Montecucco et al.   EUROPEAN HEART JOURNAL

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques

(2011) Fabrizio Montecucco et al.   EUROPEAN HEART JOURNAL

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

(2011) David H. Henry et al.   JOURNAL OF CLINICAL ONCOLOGY

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability

(2011) A. Quercioli et al.   THROMBOSIS AND HAEMOSTASIS

Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke

(2010) Fabrizio Montecucco et al.   STROKE

Total Cardiovascular Disease Burden: Comparing Intensive With Moderate Statin Therapy

(2009) Matti J. Tikkanen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE